Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
ActiveOps PLC said Thursday it has raise GBP75.7 million gross for selling shareholders in its initial public offerin ...
In these volatile times, most investors are faced with the dilemma of deciding which asset class to put their hard earned capital to work in...
San Francisco-based iShares is the world’s largest exchange traded funds (ETFs) provider with 46% of the market share. It offers a...
SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical...
Agreement Eliminates Development Milestones, Significantly Reduces Royalties and Restructures Sublicense Provisions SOUTH SAN FRANCISCO, Calif...
VANCOUVER, Sept. 7 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that its common shares will begin trading on...
VANCOUVER, Sept. 5 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) announced that its Board of...
VANCOUVER, Sept. 1 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) today confirmed that Genzyme Corp...
Proposed Acquisition Will Add Complementary Late-Stage Transplant Product CAMBRIDGE, Mass., Aug. 30 /PRNewswire-FirstCall/ -- Genzyme...
Considers Genzyme Proposal Undervalued VANCOUVER, Aug. 30 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM;...
VANCOUVER, Aug. 28 /PRNewswire-FirstCall/ -- AnorMED Inc. (AMEX:AOM;TSX:AOM) today announced that it has received approval from the NASDAQ Stock...
VANCOUVER, Aug. 28 /PRNewswire-FirstCall/ -- AnorMED Inc. (AMEX:AOM;TSX:AOM) today announced that it has called the Company's 2006 Annual and...
Increased loss result of previously announced one-time charges LANGLEY, BC, July 27 /PRNewswire-FirstCall/ -- AnorMED (TSX:AOM, AMEX:AOM) today...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.